Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. (Q50079113)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 June 2006

Language	Label	Description	Also known as
English	Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system.	scientific article published on 13 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Safety and immunogenicity of attenuated Salmonella enterica serovar Typhimurium delivering an HIV-1 Gag antigen via the Salmonella Type III secretion system. (English)

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Salmonella enterica

0 references

Alexander J Lankowski

object named as

Alexander J Lankowski

2

0 references

Camille Nelson Kotton

object named as

Camille N Kotton

1

0 references

author name string

Nathaniel Scott

3

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

David Sisul

4

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Li Mei Chen

5

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Katherine Raschke

6

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Genevieve Borders

7

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Mark Boaz

8

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Aggeliki Spentzou

9

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Jorge E Galán

10

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Elizabeth L Hohmann

11

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

language of work or name

0 references

publication date

13 June 2006

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

24

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

37-39

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

6216-6224

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

Unique characteristics of the intestinal immune system as an inductive site after antigen reencounter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Enteric pathogens as vaccine vectors for foreign antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Potential live vaccines for HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Tracking the dynamics of T-cell activation in response to Salmonella infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

HIV swiftly guts the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Interaction of Salmonella with host cells through the centisome 63 type III secretion system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Delivery of epitopes by the Salmonella type III secretion system for vaccine development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Homologs of the Shigella IpaB and IpaC invasins are required for Salmonella typhimurium entry into cultured epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

The adenovirus E4-6/7 protein transactivates the E2 promoter by inducing dimerization of a heteromeric E2F complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Salmonella typhi vaccine strain in vitro; low infectivity in human cell line U937.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag c

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Protection against murine listeriosis by oral vaccination with recombinant Salmonella expressing hybrid Yersinia type III proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Characterisation of streptomycin resistance determinants in Danish isolates of Salmonella Typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Host-parasite relations in mouse typhoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Identification of a pathogenicity island required for Salmonella survival in host cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Differential bacterial survival, replication, and apoptosis-inducing ability of Salmonella serovars within human and murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Bacterial infectious disease control by vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Transaminase elevation on placebo during phase I trials: prevalence and significance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

The influence of diet upon liver function tests and serum lipids in healthy male volunteers resident in a Phase I unit.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Identification of an intestinal immune response using peripheral blood lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Nontyphoidal salmonellosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Quantitative ex vivo analysis of functional virus-specific CD8 T lymphocytes in the blood and genital tract of HIV-infected women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Comparison of rectal swabs with fecal cultures for detection of Salmonella typhimurium in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.094

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.05.094

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/16824652

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50079113&oldid=1775332920"